EyePoint Pharmaceuticals
EYPT
#10613
Rank
NZ$48.71 M
Marketcap
NZ$0.43
Share price
-11.36%
Change (1 day)
-98.24%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -NZ$0.54 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are NZ$2.78 Million. In 2025 the company made an earning of -NZ$0.43 Billion a decrease over its 2024 earnings that were of -NZ$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.54 Billion25.46%
2025 -NZ$0.43 Billion63.24%
2024 -NZ$0.26 Billion104.29%
2023 -NZ$0.13 Billion-29.88%
2022 -NZ$0.19 Billion87.2%
2021 -NZ$96.74 Million38.58%
2020 -NZ$69.81 Million-24.56%
2019 -NZ$92.53 Million
2017 -NZ$42.21 Million22.59%
2016 -NZ$34.43 Million-8.02%
2015 -NZ$37.43 Million-296.09%
2014 NZ$19.08 M-174.02%
2013 -NZ$25.79 Million37.42%
2012 -NZ$18.77 Million-56.29%
2011 -NZ$42.93 Million-1062.38%
2010 NZ$4.46 M-250.43%
2009 -NZ$2.97 Million-89.5%
2008 -NZ$28.25 Million
2005 -NZ$17.42 Million56.99%
2004 -NZ$11.1 Million73.7%
2003 -NZ$6.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.96 Million-99.29% Bahamas
NRC Health
NRC
NZ$27.03 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA